Skip to main content

STATEC: A randomised trial of non-selective versus selective adjuvant therapy in high risk apparent stage 1 endometrial cancer

Project Member(s): De Abreu Lourenco, R., Haas, M.

Funding or Partner Organisation: Cancer Research UK
Cancer Research UK

Start year: 2018

Summary: Funded amount is £36,982.22 = AUD66,946.25 (26/09/18 xe.com) End date uncertain as agreement remains in effect for duration of Clinical Trial (5 years) related to this agreement, and completion of obligations of both parties Contract terminated 22/8/2019 due to recruitment issues

FOR Codes: Health Economics, Health Policy Economic Outcomes